NYSE:ACH Accendra Health (ACH) Stock Price, News & Analysis $0.21 0.00 (-0.62%) As of 03:58 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsNews and TrendsOptions ChainOwnershipSEC Filings About Accendra Health Stock (NYSE:ACH) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Accendra Health alerts:Sign Up Key Stats Today's Range$0.19▼$0.2250-Day Range$0.21▼$1.3252-Week Range$0.19▼$5.60Volume2.05 million shsAverage Volume2.21 million shsMarket Capitalization$16.11 millionP/E Ratio0.92Dividend YieldN/APrice Target$1.50Consensus RatingReduce Company Overview Accendra Health Inc is a nationwide provider of products, technology, and services that support health beyond the hospital by connecting patients, providers, and insurers. Through its brands, Apria and Byram Healthcare, the company delivers disposable medical supplies, integrated home healthcare equipment, and related services that help improve health outcomes and quality of life for individuals with chronic, complex, and acute health conditions. Its offerings span diabetes treatment, home respiratory therapy, and obstructive sleep apnea treatment, along with patient support services. The company also supplies a broad range of home medical equipment and patient care products, including ostomy, wound care, urology, and incontinence solutions. Read More Accendra Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks42nd Percentile Overall ScoreACH MarketRank™: 2.10536779324 of 5 starsAccendra Health scored higher than 42% of companies evaluated by MarketBeat, and ranked 416th out of 907 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.8 / 5Analyst RatingReduce Consensus RatingAccendra Health has received a consensus rating of Reduce. The company's average rating score is 1.60, and is based on no strong buy ratings, no buy ratings, 3 hold ratings, and 2 sell ratings.Upside PotentialAccendra Health has a consensus price target of $1.50, representing about 616.0% upside from its current price of $0.21.Amount of Analyst CoverageAccendra Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Accendra Health's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Accendra Health are expected to grow in the coming year, from ($0.03) to $0.09 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Accendra Health is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Accendra Health is -0.05, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted11.21% of the float of Accendra Health has been sold short.Short Interest Ratio / Days to CoverAccendra Health has a short interest ratio ("days to cover") of 4.88.Change versus previous monthShort interest in Accendra Health has recently decreased by 5.32%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAccendra Health does not currently pay a dividend.Dividend GrowthAccendra Health does not have a long track record of dividend growth. News and Social Media0.6 / 5News Sentiment0.00 News Coverage This WeekMarketBeat has tracked 2 news articles for Accendra Health this week, compared to 1 article on an average week.Search InterestOnly 1 people have searched for ACH on MarketBeat in the last 30 days. This is a decrease of -67% compared to the previous 30 days.MarketBeat Follows1 people have added Accendra Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.1 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Accendra Health insiders have not sold or bought any company stock.Percentage Held by Insiders2.29% of the stock of Accendra Health is held by insiders.Percentage Held by InstitutionsAccendra Health has minimal institutional ownership at this time.Read more about Accendra Health's insider trading history. Receive ACH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Accendra Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. ACH Stock News HeadlinesAccendra Health consensus price target decreased by 16.53% to $1.294 hours ago | msn.comAccendra Health Announces Third Quarter 2026 Earnings Release Date and Conference CallOctober 22 at 5:12 PM | markets.ft.comHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - but now he believes he's found something better. This under-the-radar company sits at the intersection of America's two most important industries, including AI, pays massive dividends, and attracted a famous money manager who put 60% of his multi-billion-dollar fund into it. Tilson is revealing the name and ticker symbol completely free - no credit card or email required.October 23 at 1:00 AM | Stansberry Research (Ad)Accendra Health Inc ACHOctober 11, 2026 | morningstar.comMAccendra Health Receives Continued Listing Standard Notice from NYSE; Intends to Cure Deficiency and Return to Compliance with NYSE Listing StandardOctober 9, 2026 | businesswire.comAccendra Health Names Kenneth Gardner-Smith As New CEOSeptember 17, 2026 | rttnews.comAccendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company’s Next Chapter of GrowthSeptember 17, 2026 | finance.yahoo.comAccendra Health Names Kenneth Gardner-Smith as President and Chief Executive Officer to Lead the Company's Next Chapter of GrowthSeptember 17, 2026 | businesswire.comSee More Headlines ACH Stock Analysis - Frequently Asked Questions How have ACH shares performed this year? Accendra Health's stock was trading at $2.64 on April 9, 2026. Since then, ACH shares have decreased by 92.1% and is now trading at $0.2095. How were Accendra Health's earnings last quarter? Accendra Health, Inc. (NYSE:ACH) announced its quarterly earnings data on Monday, August, 10th. The company reported ($0.19) EPS for the quarter, missing the consensus estimate of ($0.13) by $0.06. The business had revenue of $613.23 million for the quarter. Accendra Health had a negative net margin of 11.41% and a negative trailing twelve-month return on equity of 4.02%. Who are Accendra Health's major shareholders? Accendra Health's top institutional investors include Williams & Novak Wealth Management LLC (0.15%). How do I buy shares of Accendra Health? Shares of ACH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings8/10/2026Today10/23/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Red Zone (2m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 ACH's financial health is in the Red zone, according to TradeSmith. ACH has been in this zone for over 2 months. Industry, Sector and Symbol Stock ExchangeNYSE SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNYSE:ACH CIK75252 Webwww.accendrahealth.com Phone(804) 277-4304Fax804-723-7100Employees6,500Year Founded1882Price Target and Rating Average Price Target for Accendra Health$1.50 High Price Target$1.50 Low Price Target$1.50 Potential Upside/Downside+616.0%Consensus RatingReduce Rating Score (0-4)1.60 Research Coverage5 Analysts Profitability EPS (Trailing Twelve Months)($3.91) Trailing P/E Ratio0.92 Forward P/E RatioN/A P/E GrowthN/ANet Income-$1.10 billion Net Margins-11.41% Pretax Margin-4.36% Return on Equity-4.02% Return on Assets0.70% Debt Debt-to-Equity RatioN/A Current Ratio0.41 Quick Ratio0.30 Sales & Book Value Annual Sales$2.73 billion Price / Sales0.01 Cash Flow$3.49 per share Price / Cash Flow0.06 Book Value($5.96) per share Price / Book-0.04Miscellaneous Outstanding Shares76,900,000Free Float75,144,000Market Cap$16.11 million OptionableOptionable Beta1.57 Social Links The Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free Report This page (NYSE:ACH) was last updated on 10/23/2026 by MarketBeat.com Staff. From Our PartnersTicker Revealed: Pre-IPO Access to "Next Elon Musk" CompanyWe’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billi...Banyan Hill Publishing | SponsoredALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. doll...Porter & Company | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredDo NOT Buy SpaceX – Do This InsteadSpaceX just went public - and Whitney Tilson, Harvard MBA and 30-year Wall Street veteran, says buying in coul...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accendra Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accendra Health With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
